Hasui Y - Search Results

1

The relationship between cardiovascular complications of estrogen therapy and fibrinolysis in patients with prostatic cancer.

Hasui Y, Marutsuka K, Nishi S, Kitada S, Osada Y, Sumiyoshi A. Hasui Y, et al. Prostate. 1992;21(1):35-9. doi: 10.1002/pros.2990210104. Prostate. 1992. PMID: 1641370

2

The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer.

Hasui Y, Marutsuka K, Suzumiya J, Kitada S, Osada Y, Sumiyoshi A. Hasui Y, et al. Int J Cancer. 1992 Apr 1;50(6):871-3. doi: 10.1002/ijc.2910500607. Int J Cancer. 1992. PMID: 1555885

3

Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder.

Hasui Y, Suzumiya J, Marutsuka K, Sumiyoshi A, Hashida S, Ishikawa E. Hasui Y, et al. Cancer Res. 1989 Feb 15;49(4):1067-70. Cancer Res. 1989. PMID: 2492205

4

Striated muscle in the biopsy specimen of the prostate.

Hasui Y, Shinkawa T, Osada Y, Sumiyoshi A. Hasui Y, et al. Prostate. 1989;14(1):65-9. doi: 10.1002/pros.2990140108. Prostate. 1989. PMID: 2648348

5

Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia.

Hasui Y, Marutsuka K, Asada Y, Ide H, Nishi S, Osada Y. Hasui Y, et al. Prostate. 1994 Aug;25(2):91-6. doi: 10.1002/pros.2990250206. Prostate. 1994. PMID: 7518599

6

Effects of suramin on metastatic ability, proliferation, and production of urokinase-type plasminogen activator and plasminogen activator inhibitor type 2 in human renal cell carcinoma cell line SN12C-PM6.

Marutsuka K, Hasui Y, Asada Y, Naito S, Osada Y, Sumiyoshi A. Marutsuka K, et al. Among authors: hasui y. Clin Exp Metastasis. 1995 Mar;13(2):116-22. doi: 10.1007/BF00133616. Clin Exp Metastasis. 1995. PMID: 7882614

7

The content of urokinase-type plasminogen activator and tumor recurrence in superficial bladder cancer.

Hasui Y, Marutsuka K, Nishi S, Kitada S, Osada Y, Sumiyoshi A. Hasui Y, et al. J Urol. 1994 Jan;151(1):16-9; discussion 19-20. doi: 10.1016/s0022-5347(17)34861-9. J Urol. 1994. PMID: 8254803

8

[Urokinase-type plasminogen activator antigen as a prognostic factor in bladder cancer].

Hasui Y, Nishi S, Kitada S, Osada Y. Hasui Y, et al. Nihon Hinyokika Gakkai Zasshi. 1993 Sep;84(9):1624-8. doi: 10.5980/jpnjurol1989.84.1624. Nihon Hinyokika Gakkai Zasshi. 1993. PMID: 8411819 Free article. Japanese.

9

Prognostic value of urokinase-type plasminogen activator in patients with superficial bladder cancer.

Hasui Y, Marutsuka K, Asada Y, Osada Y. Hasui Y, et al. Urology. 1996 Jan;47(1):34-7. doi: 10.1016/s0090-4295(99)80378-1. Urology. 1996. PMID: 8560659

10

The prognostic significance of vascular invasion in upper urinary tract transitional cell carcinoma.

Hasui Y, Nishi S, Kitada S, Osada Y, Asada Y. Hasui Y, et al. J Urol. 1992 Dec;148(6):1783-5. doi: 10.1016/s0022-5347(17)37028-3. J Urol. 1992. PMID: 1433607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters